bioRxivBioinformaticsPreprint
Single nucleotide polymorphisms of the c-MYC gene’s relationship with formation of Burkitt’s lymphoma using bioinformatics analysis
Anfal Osama Mohamed SatiiD, Weaam Anwer Osman, Enas Abdalla Mohammed Ahmedon, Safa YousifiD, Enas dk. DawoudiD, Alaa Ibrahim Mohammed Hassan, Moshtaha Ali Ibrahim Elsammani, Mohamed Ahmed SalihiD
Abstract
Burkitts lymphoma (BL) is an aggressive form of non-Hodgkin lymphoma, originates from germinal center B cells, MYC gene (MIM ID 190080) is an important proto-oncogene transcriptional factor encoding a nuclear phosphoprotein for central cellular processes. Dysregulated expression or function of c-MYC is one of the most common abnormalities in BL. This study focused on the investigation of the possible role of single nucleotide polymorphisms (SNPs) in MYC gene associated with formation of BL.\n\nMYC SNPs were obtained from NCBI database. SNPs in the coding region that are non-synonymous (nsSNPs) were analysed by multiple programs such as SIFT, Polyphen2, SNPs&GO, PHD-SNP and I-mutant. In this study, a total of 286 Homo sapiens SNPs were found. Roughly, forty-eight of them were deleterious and were furtherly investigated.\n\nEight SNPs were considered most disease causing [rs4645959 (N26S), rs4645959 (N25S), rs141095253 (P396L), rs141095253 (P397L), rs150308400 (C233Y), rs150308400 (C147Y), rs150308400 (C147Y), rs150308400 (C148Y)] according to the four softwares used. Two of which have not been reported previously [rs4645959 (N25S), rs141095253 (P396L)]. SNPs analysis helps is a diagnostic marker which helps in diagnosing and consequently, finding therapeutics for clinical diseases. This is through SNPs genotyping arrays and other techniques. Thus, it is highly recommended to confirm the findings in this study in vivo and in vitro.
- organism: human
- assay: GWAS summary statistics
- research focus: differential expression
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Alternative c-MYC mRNA transcripts as an additional tool for c-Myc2 and c-MycS production in BL60 tumors.
D. IBRAHIM, N. FAUMONT, … A. OULMOUDEN·bioRxiv·Feb 18, 2022
- mRNA deep sequencing profiling and integrative miRNA-mRNA network analysis in pediatric Burkitt leukemia and lymphoma
Teresa M. Cardesa‐Salzmann, Verónica Celis, … Carl-Friedrich Classen·bioRxiv·Oct 27, 2026
- MDM4 is an essential disease driver targeted by 1q gain in Burkitt lymphoma
Jennifer Hüllein, Mikołaj Słabicki, … Thorsten Zenz·bioRxiv·Apr 9, 2018
- Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis
M. Herold, M. A. Potts, … A. Strasser·Cell Death & DifferentiationPeer-reviewed·Jun 1, 2023
- MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, and enhances the viral infection of Burkitt lymphoma cells
E. Molina, L. Garcia-Gutierrez, … J. Leon·bioRxiv·Dec 28, 2022
- Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
Man Chun John Ma, Saber Tadros, … Michael R. Green·HaematologicaPeer-reviewed·Apr 1, 2021